Results 301 to 310 of about 8,852,069 (358)

Correction: Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy. [PDF]

open access: yesJ Exp Med
Tang Y   +23 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

HOST CONDITIONING IN EXPERIMENTAL CHEMOTHERAPY*

Annals of the New York Academy of Sciences, 1958
J E, PALM   +3 more
openaire   +3 more sources

Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

New England Journal of Medicine, 2023
BACKGROUND Approximately 20% of patients with non-small-cell lung cancer (NSCLC) receive a diagnosis of stage III disease. There is no current consensus regarding the most appropriate treatment for these patients.
M. Provencio   +29 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy